Novartis AG EBITDA 2010-2024 | NVS

Novartis AG EBITDA for the quarter ending December 31, 2024 was $5.190B, a 23.37% increase year-over-year.

  • Novartis AG 2024 EBITDA was 20.658B, a 13.81% increase from 2023.
  • Novartis AG 2023 EBITDA was 18.152B, a 21.74% increase from 2022.
  • Novartis AG 2022 EBITDA was 14.911B, a 27.56% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Novartis AG EBITDA 2010-2024 | NVS

  • Novartis AG 2024 EBITDA was 20.658B, a 13.81% increase from 2023.
  • Novartis AG 2023 EBITDA was 18.152B, a 21.74% increase from 2022.
  • Novartis AG 2022 EBITDA was 14.911B, a 27.56% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$827.9B
Johnson & Johnson (JNJ)$384.4B
Novo Nordisk (NVO)$375.8B
AbbVie (ABBV)$354.6B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Pfizer (PFE)$146.8B
Sanofi (SNY)$137.4B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B